Abstract The RAPNO criteria for pediatric low-grade gliomas (pLGGs), designed to improve upon the RANO criteria, are increasingly being employed to assess treatment responses. However, the adoption of the RAPNO guidelines in our clinical trials has revealed some notable challenges that stymie their practical implementation. These challenges should be addressed to render the guidelines more comprehensive and facilitate their widespread adoption. Definition of tumor burden should be modified: The current guidelines define tumor burden as the sum of the products of the longest tumor diameter and its longest perpendicular diameter. While this approach generally works, implementing it in optic pathway gliomas involving the nerve and subtotally resected pLGGs where the longest diameter is often disproportionally larger than the perpendicular diameter creates a challenge. The result is an inaccurate measure of tumor burden as well as poor reproducibility. Progressive disease should be confirmed with follow-up imaging. Unlike response confirmation, guidelines do not recommend confirmation of progression. Since pLGGs grow slowly, the change in diameters between two consecutive scans is often so small that it can be indistinguishable from measurement error. This is particularly problematic in smaller tumors and in diffusely infiltrating tumors, in which minor measurement change can erroneously shift response to progressive disease. Definition of target lesion should be more specific: pLGGs can recur focally without involving the entire previously treated residual tumor. Based on RAPNO guidelines, the target lesion includes both the growing and the stable residual components. This poses a challenge and can result in a serious underestimate of efficacy, particularly with biologic therapy, when the response of the recurrent focal tumor is major or complete but, by the current criteria, only registers as stable disease or minor response. Our discussion will show real-world examples of these challenges and propose recommendations to enhance the practical application of RAPNO criteria.
Read full abstract